Carmine Carbone

18PUBLICATIONS
49CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 07, 2026
Multi-omic single nuclei profiling of murine pancreas shows dynamic epigenetic heterogeneity of acinar cells.

|May 18, 2026
Transcriptional and Epigenetic Plasticity Drive an Alternative Non-clonal Mechanism of Resistance to Kras G12D Inhibition in Pancreatic Cancer.

|Apr 22, 2026
c-FLIP as a master regulator of immune homeostasis and disease mechanisms.

|Jan 08, 2025
Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice.

Carmine Carbone, Roberto De Luca, Emanuele Puca

|Dec 05, 2024
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance.

A Esposito, A Agostini, G Quero

|Dec 03, 2024
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.

Lisa Veghini, Davide Pasini, Rui Fang

Pageof 3

Frequent Collaborators

7 joint publications

Geny Piro

6 joint publications

Vincenzo Corbo

3 joint publications

Giampaolo Tortora

3 joint publications

Aldo Scarpa